Literature DB >> 18667095

Anxiety in middle adulthood: effects of age and time on the 14-year course of panic disorder, social phobia and generalized anxiety disorder.

H J Ramsawh1, S D Raffa, M Orlando Edelen, R Rende, M B Keller.   

Abstract

BACKGROUND: Much about the long-term course of anxiety disorders is unknown. The present study utilizes a naturalistic, longitudinal, short-interval follow-up design to elucidate the course of anxiety disorders over 14 years in a largely middle-aged adult sample recruited from out-patient psychiatry and primary care facilities.
METHOD: The sample consisted of 453 participants with a diagnosis of panic disorder (PD), social phobia (SP) and/or generalized anxiety disorder (GAD). Anxiety symptom ratings were tracked using weekly psychiatric status ratings (PSRs). Controlling for demographic and clinical variables, the course of PD, GAD and SP were examined using longitudinal growth models, with the most severe PSR at each follow-up point as the main outcome variable.
RESULTS: PSRs significantly decreased in severity over time in each of the three disorders. In the interaction effects models, age x time had a significant effect on course for PD and GAD, but not for SP, in that older age was associated with lower PSRs over time.
CONCLUSIONS: The present findings suggest that the severity of anxiety disorders declines over time, although this decline is modest and depends on the specific disorder being assessed. Older individuals with PD and GAD have a better prognosis than their younger counterparts, as their course is characterized by a steeper decline in severity. The present findings provide important information about the course of anxiety disorders in mid-life.

Entities:  

Mesh:

Year:  2008        PMID: 18667095      PMCID: PMC3679349          DOI: 10.1017/S0033291708003954

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  38 in total

1.  Infrequency of "pure" GAD: impact of psychiatric comorbidity on clinical course.

Authors:  S E Bruce; J T Machan; I Dyck; M B Keller
Journal:  Depress Anxiety       Date:  2001       Impact factor: 6.505

2.  One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites.

Authors:  D A Regier; J H Boyd; J D Burke; D S Rae; J K Myers; M Kramer; L N Robins; L K George; M Karno; B Z Locke
Journal:  Arch Gen Psychiatry       Date:  1988-11

3.  Aging and panic disorder: phenomenology, comorbidity, and risk factors.

Authors:  Javaid I Sheikh; Pamela J Swales; Eve B Carlson; Steve E Lindley
Journal:  Am J Geriatr Psychiatry       Date:  2004 Jan-Feb       Impact factor: 4.105

4.  A diagnostic interview: the schedule for affective disorders and schizophrenia.

Authors:  J Endicott; R L Spitzer
Journal:  Arch Gen Psychiatry       Date:  1978-07

5.  Chronicity, relapse, and illness--course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up.

Authors:  Kimberly A Yonkers; Steven E Bruce; Ingrid R Dyck; Martin B Keller
Journal:  Depress Anxiety       Date:  2003       Impact factor: 6.505

6.  Clinical and psychosocial outcome of patients affected by panic disorder with or without agoraphobia: results from a naturalistic follow-up study.

Authors:  Bernardo Carpiniello; Antonella Baita; Mauro Giovanni Carta; Rossella Sitzia; Adolfo Maria Macciardi; Stefano Murgia; Alfredo Carlo Altamura
Journal:  Eur Psychiatry       Date:  2002-11       Impact factor: 5.361

7.  Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication.

Authors:  A M Ruscio; T A Brown; W T Chiu; J Sareen; M B Stein; R C Kessler
Journal:  Psychol Med       Date:  2007-11-02       Impact factor: 7.723

8.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06

9.  Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults.

Authors:  K A Christie; J D Burke; D A Regier; D S Rae; J H Boyd; B Z Locke
Journal:  Am J Psychiatry       Date:  1988-08       Impact factor: 18.112

10.  Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?

Authors:  Steven E Bruce; Russell G Vasile; Robert M Goisman; Carl Salzman; Megan Spencer; Jason T Machan; Martin B Keller
Journal:  Am J Psychiatry       Date:  2003-08       Impact factor: 18.112

View more
  18 in total

Review 1.  Burden of anxiety disorders in pediatric medical settings: prevalence, phenomenology, and a research agenda.

Authors:  Holly J Ramsawh; Denise A Chavira; Murray B Stein
Journal:  Arch Pediatr Adolesc Med       Date:  2010-10

2.  Pattern of structural brain changes in social anxiety disorder after cognitive behavioral group therapy: a longitudinal multimodal MRI study.

Authors:  V R Steiger; A B Brühl; S Weidt; A Delsignore; M Rufer; L Jäncke; U Herwig; J Hänggi
Journal:  Mol Psychiatry       Date:  2016-12-06       Impact factor: 15.992

3.  Prevalence of lifetime DSM-IV affective disorders among older African Americans, Black Caribbeans, Latinos, Asians and non-Hispanic White people.

Authors:  Amanda Toler Woodward; Robert Joseph Taylor; Kai McKeever Bullard; Maria P Aranda; Karen D Lincoln; Linda M Chatters
Journal:  Int J Geriatr Psychiatry       Date:  2011-10-10       Impact factor: 3.485

4.  Executive function and other cognitive deficits are distal risk factors of generalized anxiety disorder 9 years later.

Authors:  Nur Hani Zainal; Michelle G Newman
Journal:  Psychol Med       Date:  2017-12-11       Impact factor: 7.723

5.  Age of onset, clinical characteristics, and 15-year course of anxiety disorders in a prospective, longitudinal, observational study.

Authors:  Holly J Ramsawh; Risa B Weisberg; Ingrid Dyck; Robert Stout; Martin B Keller
Journal:  J Affect Disord       Date:  2011-02-05       Impact factor: 4.839

6.  Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder.

Authors:  John R Keefe; Jun J Mao; Irene Soeller; Qing S Li; Jay D Amsterdam
Journal:  Phytomedicine       Date:  2016-10-24       Impact factor: 5.340

7.  Two-year course of generalized anxiety disorder, social anxiety disorder, and panic disorder in a longitudinal sample of African American adults.

Authors:  Nicholas J Sibrava; Courtney Beard; Andri S Bjornsson; Ethan Moitra; Risa B Weisberg; Martin B Keller
Journal:  J Consult Clin Psychol       Date:  2013-09-16

Review 8.  Worry and generalized anxiety disorder: a review and theoretical synthesis of evidence on nature, etiology, mechanisms, and treatment.

Authors:  Michelle G Newman; Sandra J Llera; Thane M Erickson; Amy Przeworski; Louis G Castonguay
Journal:  Annu Rev Clin Psychol       Date:  2013       Impact factor: 18.561

Review 9.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

10.  Time of day effects on the relationship between daily sleep and anxiety: An ecological momentary assessment approach.

Authors:  Rebecca C Cox; Sonya K Sterba; David A Cole; Raghu P Upender; Bunmi O Olatunji
Journal:  Behav Res Ther       Date:  2018-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.